Por: ABC News Health August 21, 2023
The U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV). The vaccine would be given during late pregnancy to reduce the risk of severe RSV infection among newborns.However, the vaccine won't be available on pharmacy shelves for pregnant women immediately. It is still awaiting an evaluation from an expert panel at the Centers for Disease Control... + full article
New York Post USA Life July 18, 2023
The Food and Drug Administration on Monday approved a new drug, Beyfortus (nirsevimab), to protect young children from the deadly infection known as . Worldwide, RSV is the second-leading cause of death during the first year of a newborn’s life, second only to , according to .... + más
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
Strong RSV vaccine data lifts hopes after years of futility | ABC News
New York Post USA Life February 23, 2023
A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August. Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and Drug Administration is reportedly expediting its review approval process. The FDA... + más
Strong RSV vaccine data lifts hopes after years of futility | WPLG Local 10
ABC7 USA Health February 21, 2023
A Pfizer logo is seen in this illustration, May 1, 2022.Dado Ruvic/Reuters, FILERSV usually causes mild, cold-like symptoms, but can become serious, especially for infants and older adults. Premature infants and young children with weakened immune systems, congenital heart or... + más
ABC7 USA World February 21, 2023
against , could be approved by August.Pfizer, the maker of the vaccine, that the U.S. Food and Drug Administration has accepted its application for review and will make a decision on whether or not to approve the vaccine by August 2023.If approved, RSVpreF would help protect... + más
CNBC USA Health November 11, 2022
Diane Macdonald Stockbyte Getty ImagesEven healthy infants face a considerable risk of hospitalization from respiratory syncytial virus, according to a large European study published Thursday.Dutch and British scientists, in a study published in Lancet Respiratory Medicine,... + más
Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7
CNN USA Health November 01, 2022
CNN — Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that it will end enrollment in the study and submit for US Food and Drug Administration approval by the end of the year. RSV is a common... + más
Pfizer announces promising developments for 1st maternal RSV vaccine | ABC News
When Will the RSV Vaccine be Available? Pfizer Jab Shows 'Positive' Results | Newsweek
10 WBNS USA Health November 01, 2022
NEW YORK — shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals each fall. The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be... + más
About iurex | Privacy Policy | Disclaimer |